Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease

• Príomhchruthaitheoirí: Fuyu Ito (Údar), Toshiaki Oharaseki (Údar), Daisuke Tsukui (Údar), Yoshitaka Kimura (Údar), Tamiko Yanagida (Údar), Fukuko Kishi (Údar), Yoshio Yamakawa (Údar), Yosuke Kameoka (Údar), Shoichi Suzuki (Údar), Kazuko Uno (Údar), Osamu Suzuki (Údar), Noriko N. Miura (Údar), Naohito Ohno (Údar), Kei Takahashi (Údar), Hajime Kono (Údar), Kazuo Suzuki (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: BMC, 2022-12-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Abstract Background Kawasaki disease (KD) is usually treated with high-dose intravenous immunoglobulin (IVIg) as severe infectious and other diseases. Due to issues that are associated with immunoglobulin preparation, such as the risk of possible contamination by infectious agents and limited blood...